Cargando…

Histamine in murine narcolepsy: What do genetic and immune models tell us?

An increased number of histaminergic neurons, identified by labeling histidine‐decarboxylase (HDC) its synthesis enzyme, was unexpectedly found in patients with narcolepsy type 1 (NT1). In quest for enlightenment, we evaluate whether an increase in HDC cell number and expression level would be detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Melzi, Silvia, Morel, Anne‐Laure, Scoté‐Blachon, Céline, Liblau, Roland, Dauvilliers, Yves, Peyron, Christelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877734/
https://www.ncbi.nlm.nih.gov/pubmed/34672414
http://dx.doi.org/10.1111/bpa.13027
_version_ 1784658489484771328
author Melzi, Silvia
Morel, Anne‐Laure
Scoté‐Blachon, Céline
Liblau, Roland
Dauvilliers, Yves
Peyron, Christelle
author_facet Melzi, Silvia
Morel, Anne‐Laure
Scoté‐Blachon, Céline
Liblau, Roland
Dauvilliers, Yves
Peyron, Christelle
author_sort Melzi, Silvia
collection PubMed
description An increased number of histaminergic neurons, identified by labeling histidine‐decarboxylase (HDC) its synthesis enzyme, was unexpectedly found in patients with narcolepsy type 1 (NT1). In quest for enlightenment, we evaluate whether an increase in HDC cell number and expression level would be detected in mouse models of the disease, in order to provide proof of concepts reveling possible mechanisms of compensation for the loss of orexin neurons, and/or of induced expression as a consequence of local neuroinflammation, a state that likely accompanies NT1. To further explore the compensatory hypothesis, we also study the noradrenergic wake‐promoting system. Immunohistochemistry for HDC, orexin, and melanin‐concentrating hormone (MCH) was used to count neurons. Quantitative‐PCR of HDC, orexin, MCH, and tyrosine‐hydroxylase was performed to evaluate levels of mRNA expression in the hypothalamus or the dorsal pons. Both quantifications were achieved in genetic and neuroinflammatory models of narcolepsy with major orexin impairment, namely the orexin‐deficient (Orex‐KO) and orexin‐hemagglutinin (Orex‐HA) mice respectively. The number of HDC neurons and mRNA expression level were unchanged in Orex‐KO mice compared to controls. Similarly, we found no change in tyrosine‐hydroxylase mRNA expression in the dorsal pons between groups. Further, despite the presence of protracted local neuroinflammation as witnessed by the presence of reactive microglia, we found no change in the number of neurons nor the expression of HDC in Orex‐HA mice compared to controls. Importantly, no correlation was found in all conditions between HDC and orexin. Our findings indicate that, in mice, the expression of histamine and noradrenalin, two wake‐promoting systems, are not modulated by orexin level whether the lack of orexin is constitutive or induced at adult age, showing thus no compensation. They also show no recruitment of histamine by local neuroinflammation. Further studies will be needed to further define the role of histamine in the pathophysiology of NT1.
format Online
Article
Text
id pubmed-8877734
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88777342022-03-01 Histamine in murine narcolepsy: What do genetic and immune models tell us? Melzi, Silvia Morel, Anne‐Laure Scoté‐Blachon, Céline Liblau, Roland Dauvilliers, Yves Peyron, Christelle Brain Pathol Research Articles An increased number of histaminergic neurons, identified by labeling histidine‐decarboxylase (HDC) its synthesis enzyme, was unexpectedly found in patients with narcolepsy type 1 (NT1). In quest for enlightenment, we evaluate whether an increase in HDC cell number and expression level would be detected in mouse models of the disease, in order to provide proof of concepts reveling possible mechanisms of compensation for the loss of orexin neurons, and/or of induced expression as a consequence of local neuroinflammation, a state that likely accompanies NT1. To further explore the compensatory hypothesis, we also study the noradrenergic wake‐promoting system. Immunohistochemistry for HDC, orexin, and melanin‐concentrating hormone (MCH) was used to count neurons. Quantitative‐PCR of HDC, orexin, MCH, and tyrosine‐hydroxylase was performed to evaluate levels of mRNA expression in the hypothalamus or the dorsal pons. Both quantifications were achieved in genetic and neuroinflammatory models of narcolepsy with major orexin impairment, namely the orexin‐deficient (Orex‐KO) and orexin‐hemagglutinin (Orex‐HA) mice respectively. The number of HDC neurons and mRNA expression level were unchanged in Orex‐KO mice compared to controls. Similarly, we found no change in tyrosine‐hydroxylase mRNA expression in the dorsal pons between groups. Further, despite the presence of protracted local neuroinflammation as witnessed by the presence of reactive microglia, we found no change in the number of neurons nor the expression of HDC in Orex‐HA mice compared to controls. Importantly, no correlation was found in all conditions between HDC and orexin. Our findings indicate that, in mice, the expression of histamine and noradrenalin, two wake‐promoting systems, are not modulated by orexin level whether the lack of orexin is constitutive or induced at adult age, showing thus no compensation. They also show no recruitment of histamine by local neuroinflammation. Further studies will be needed to further define the role of histamine in the pathophysiology of NT1. John Wiley and Sons Inc. 2021-10-21 /pmc/articles/PMC8877734/ /pubmed/34672414 http://dx.doi.org/10.1111/bpa.13027 Text en © 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Melzi, Silvia
Morel, Anne‐Laure
Scoté‐Blachon, Céline
Liblau, Roland
Dauvilliers, Yves
Peyron, Christelle
Histamine in murine narcolepsy: What do genetic and immune models tell us?
title Histamine in murine narcolepsy: What do genetic and immune models tell us?
title_full Histamine in murine narcolepsy: What do genetic and immune models tell us?
title_fullStr Histamine in murine narcolepsy: What do genetic and immune models tell us?
title_full_unstemmed Histamine in murine narcolepsy: What do genetic and immune models tell us?
title_short Histamine in murine narcolepsy: What do genetic and immune models tell us?
title_sort histamine in murine narcolepsy: what do genetic and immune models tell us?
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877734/
https://www.ncbi.nlm.nih.gov/pubmed/34672414
http://dx.doi.org/10.1111/bpa.13027
work_keys_str_mv AT melzisilvia histamineinmurinenarcolepsywhatdogeneticandimmunemodelstellus
AT morelannelaure histamineinmurinenarcolepsywhatdogeneticandimmunemodelstellus
AT scoteblachonceline histamineinmurinenarcolepsywhatdogeneticandimmunemodelstellus
AT liblauroland histamineinmurinenarcolepsywhatdogeneticandimmunemodelstellus
AT dauvilliersyves histamineinmurinenarcolepsywhatdogeneticandimmunemodelstellus
AT peyronchristelle histamineinmurinenarcolepsywhatdogeneticandimmunemodelstellus